Radiomics of rectal cancer for predicting distant metastasis and overall survival.

Background: Rectal cancer (RC) patient stratification by different factors may yield variable results. Therefore, more efficient prognostic biomarkers are needed for improved risk stratification, personalized treatment, and prognostication of RC patients.

Aim: To build a novel model for predicting the presence of distant metastases and 3-year overall survival (OS) in RC patients.